Bio Green Med Solution BGMS
NASDAQ BGMS
$0.92 +0.08 (+9.90%)
As of: Sep 3, 2026 · 2:03 PM EDT

Bio Green Med Solution (BGMS) EBITDA Margin Growth (3y) (2013 - 2026)

Analysis

Bio Green Med Solution (BGMS) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 141.39 Bn 133.54 Bn 2.84 Bn -377.00
2 Regeneron Pharmaceuticals 86.67 Bn 78.68 Bn 3.93 Bn -204.00
3 Argenx Se 65.00 Bn 59.82 Bn 1.37 Bn 7,045.00
4 Moderna 57.38 Bn 52.24 Bn 52.00 Mn -1,934.00
5 Revolution Medicines 44.46 Bn 44.46 Bn - -
6 BeOne Medicines 40.47 Bn 35.37 Bn 1.53 Bn 7,261.00
7 Alnylam Pharmaceuticals 35.36 Bn 32.05 Bn 992.69 Mn 9,003.00
8 Royalty Pharma 28.30 Bn 27.46 Bn - -2,649.00
9 Insmed 27.40 Bn 26.24 Bn 358.27 Mn 30,461.00
10 Bio Green Med Solution 5.12 Mn 1.33 Mn 79,000.00 146,514.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 146,514.00
Dec 31, 2018 -72,623.00
Dec 31, 2016 18,505.00
Sep 30, 2016 17,931.00
Jun 30, 2016 -12,021.00
Mar 31, 2016 -78,268.00
Dec 31, 2015 9.22 Mn
Sep 30, 2015 879,374.00
Jun 30, 2015 1.34 Mn
Mar 31, 2015 90,002.00
Dec 31, 2014 -27,975.00
Sep 30, 2014 159,443.00
Jun 30, 2014 69,411.00
Mar 31, 2014 113,384.00
Dec 31, 2013 -185,708.00
Sep 30, 2013 63,906.00
Jun 30, 2013 211,223.00